INJECTION DRUG USE IN METROPOLITAN CINCINNATI Judith Feinberg, MD Professor of Medicine University of Cincinnati College of Medicine November 12, 2012.

Slides:



Advertisements
Similar presentations
African Americans and Hepatitis C
Advertisements

Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,
Adolescent HIV In Metro Atlanta: Updates & Opportunities.
Hepatitis C Rapid Antibody Testing Among At-Risk Populations, Arizona, 2014 Felicia McLean Public Health Associate Office for State, Tribal, Local and.
‏Hepatitis B Eliminating Transmission Preventing Disease* John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention * The.
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
2013 Update Illustrating HIV/AIDS in the United States New York, NY.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Hepatitis C.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
EVALUATION OF A SAFE INJECTION PROJECT IN UZBEKISTAN Dr. Erkin I. Musabaev Institute of Postgraduate Medical Education, Tashkent Uzbekistan Health Ministry.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
Sex, drugs and alcohol – impact on health services Dr Marion Lyons Josie Smith NPHS.
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
HIV and Injection Drug Use
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Safer Needle Devices: Protecting Health Care Workers.
Safer Needle Devices: Protecting Health Care Workers.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
THE BODY PRO The HIV Resource for Health Care Professionals Copyright © 2009 The HealthCentral Network, Inc. All rights reserved. This activity is jointly.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Preventing Medical Complications of Injection Drug Use Keith Heinzerling, MD, MPH UCLA Seminars in Addiction Psychiatry Course August 11, 2005.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
© 2007 McGraw-Hill Higher Education. All rights reserved. Wound Care and Bloodborne Pathogens Amber Giacomazzi, MS, ATC.
Introduction About HIV/AIDS in Hangzhou Hangzhou Center For Disease Control And Prevention — by Zhao Gang — by Zhao Gang.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
Hepatitis A, B, and C Its prevention, nursing management, and medical treatment Presented by: Dave Jay S. Manriquez RN.
TB, STDs, HIV, HEPATITIS C and SUBSTANCE ABUSE: A Local Perspective Paula Kriner, MPH Imperial County Public Health Department Management of TB, STDs,
The Swiss Population In 2001 Resident population: 7,258,500 Population density: 176 per Km 2 Foreign nationals: 20.1% (~1,460,000) Excess of births over.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Pennsylvania: The State of HCV 2015
OVERVIEW OF PROJECT INSPIRE NYC Marie Bresnahan, MPH Project Director May 20,
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Substance Abuse Treatment and HIV in Iran
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Challenges Facing Communities Combating Hepatitis C Dr. Virginia A. Caine, M.D. Director, Marion County Public Health Department Associate Professor of.
Jennifer R. Havens, PhD, MPH Associate Professor
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.
Hepatitis C Dr R V S N Sarma., M.D Consultant Physician.
Illustrating HIV/AIDS in the United States 2014 Update Miami (Miami-Dade County, a division in the Miami MSA), FL.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
Lessons from Indiana HIV and Hepatitis C Wisconsin HIV Community Planning Statewide Action Planning Group Meeting Green Lake June 25,
Persons with Serious Mental Illness Michael B. Blank, PhD Center for Mental Health Policy and Services Research University of Pennsylvania HIV Screening.
C LINICAL PRESENTATIONS RELATED TO HEPATITIS AND ALCOHOL, PRACTICE IMPLICATIONS OF NEW THERAPIES : AN ANALYSIS OF THE F RENCH N ATIONAL H OSPITAL.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Diane M. Janowicz, MD Assistant Professor of Clinical Medicine Indiana University School of Medicine Indianapolis, Indiana Persistent Challenges of HIV.
Health Risks Resulting from Injection Drug Use. Drugs most commonly used through injection are: Cocaine Heroine Methamphetamines Steroids.
Hepatitis C and Sexual & Reproductive Health Graham Mackintosh, Training & Capacity Officer Lesley Bon, Patient Involvement Officer.
Hepatitis C.
Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Hepatitis C Incidence and Prevalence in the U.S.
Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,
Jonathan Mermin, MD, MPH RADM, USPHS
Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D
Needle exchange program
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
Presentation transcript:

INJECTION DRUG USE IN METROPOLITAN CINCINNATI Judith Feinberg, MD Professor of Medicine University of Cincinnati College of Medicine November 12, 2012

Disclosures  Advisory Board: Janssen, GlaxoSmithKline/ViiV & Merck  Shareholder: Pfizer (stock)  Grant Recipient: Janssen, Tobira, GSK/ViiV, Boehringer Ingelheim & Bristol Myers Squibb  Speakers Bureau: Janssen, Merck, BMS & GSK/ViiV

Endocarditis Admissions at University Hospital

*also includes Batavia, Blue Ash, Amberley, Butler County, Clermont County, Cleves, Madeira, Mariemont

UH Endocarditis Study,  2-fold increase in hospital admissions for endocarditis  4-fold increase in patients with chronic hepatitis C  6-fold increase in positive toxicology screens  reflects a sharp local increase in IDU, from 1999 to 2009  These rates underestimate the true numbers because most endocarditis patients were not tested

CaseDemographics 13 day hospitalization cost: Age, race, sex IVDU HCV HIV Insurance $85, year old black male Yes No None (Medicaid pending) 20 day hospitalization cost (AVR): Age, race, sex IVDU HCV HIV Insurance $173, year old black male Yes No Molina (Medicaid) 17 day hospitalization cost (AVR): Age, race, sex IVDU HCV HIV Insurance $267, year old white male Yes No None (Medicaid pending) Hospital costs* for 3 representative UH admissions * does not include physician charges or 5-7 week stay in SNF for IV antibiotics

Who is at greatest risk for encountering used syringes?  First Responders  Police  Firemen  EMTs  Sanitation workers  Parks & recreation workers  Children

Health Risks for First Responders  HIV  Acute & chronic hepatitis C (HCV)  Chronic HCV #1 reason for liver transplantation in the U.S.  Acute & chronic hepatitis B (HBV)  HIV plus chronic HCV and/or chronic HBV co- infection  Infections at puncture site (cellulitis, abscesses)

Health Risks for IDUs  All of the infections listed for First Responders, plus..  Bloodborne bacterial infections  Endocarditis (infection of lining of heart)  Osteomyelitis (bone infection)  Septic emboli, esp lung (infections that are spread throughout the body by blood)  Brain abscesses  All of which require at least 6-8 weeks of intravenous antibiotics, plus other interventions

Hepatitis C: Fate of Acute Infection 15% Chronic 85% Spontaneous Resolution (15%) Alter MJ, et al. N Eng J Med. 1999;341: Chronic Infection (85%) Note: chronic hep C is the most common reason for liver transplantation in the U.S.

Cincinnati IDU Survey Data  N = 101 completed surveys  4 reported already being HIV+  26 reported already being HCV+  All reported sexual behavior risk factors in addition to drug use for HIV & HCV transmission or acquisition

Cincinnati IDU Survey Data GenderRace Male Female

Cincinnati IDU Survey Data Age yrs yrs yrs yrs.

Cincinnati IDU Survey Data  Age at first use of IV and other drugs Age Percentage

Cincinnati IDU Survey Data  69/101 (68%) reported finding used/dirty syringes

Cincinnati IDU Survey Data  39% reused found syringes, half without cleaning them (many used inadequate cleaning methods)

PLWHCV* by Zip Code, 2009 * people living with hepatitis C

Heroin Arrests by Zip Code, 2009 *

PLWHA* by Zip Code, 2009 * people living with HIV/AIDS

Location of Most Overdose Deaths, Metro Cincinnati

Lower Price HIll

Lower Price Hill

Fairview

Outside Daycare Center, near UC

Daycare Center Backyard, near UC

Syringe Exchange Programs (SEPs)  16 peer-reviewed scientific studies performed from 1996 to 2007 have shown that SEPs reduce the transmission of HIV, hepatitis B and hepatitis C  6 studies looked at the effect on substance abuse, and all found that this type of program does not promote substance abuse  8 studies also looked at drug treatment enrollment, and all found that SEPs increase enrollment in drug treatment programs

Why SEPs Work to Protect the Public  “one for one” exchange of sterile syringe for a dirty one gives street value to used syringes  IDUs will collect used syringes found in public places to turn in for clean ones  this helps ‘police’ public places and keep them needle-free…  …protecting first responders, other public workers, and children as well as IDUs themselves from chronic viral and serious bacterial infections

Services/Logistics of Proposed Cincinnati SEP (“Cincinnati Exchange Project”)  “ one for one” program: a sterile syringe for a dirty one  safer sex materials and bleach kits for appropriate cleaning or used syringes  naloxone kits for preventing fatal overdoses  rapid tests for HIV, hepatitis C, and pregnancy  abscess and wound care education  linkage to medical care  referrals to mental health services & drug treatment programs  CEP will utilize a customized RV, with rotating locations  plan on 3 initial sites, based on our zip code data